Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ENTOMED NORGE AS
AS
Active
Org 984026323
Olaf Helsets Vei 5, 0694 Oslo
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2001
2 employees
www.entomed.no
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 6,8M
+32% vs 2023
EBITDA margin
14.3%
+7% vs 2023
Equity ratio
24.4%
Financial strength
Net profit 2024
NOK 824K
+9% vs 2023
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
1M
2020
1M
0%
2021
1M
0%
2022
1M
0%
2023
1M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 6,8M
+32%
EBITDA
NOK 977K
+7%
Net profit
NOK 824K
+9%
Total assets
NOK 5M
+81%
Equity
NOK 1,2M
+2%
Employees
2
—
Company information
Legal name
ENTOMED NORGE AS
Org number
984026323
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
17. desember 2001
Share capital
NOK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene eller daglig leder alene.
Company purpose
Salg og distribusjon av medisinsk utstyr og hva som hermed står i forbindelse
Contact
Address
Olaf Helsets Vei 5, 0694 Oslo
Website
www.entomed.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
2M
4M
6M
8M
4M
2020
5M
2021
5M
2022
5M
2023
7M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
1M
2020
1M
2021
1M
2022
1M
2023
1M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
4 006
5 301
4 864
5 146
6 816
Staff expenses
−1 209
−1 438
−1 124
−1 124
−1 132
EBITDA
522
1 097
811
916
977
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
522
1 097
811
916
977
Net financials
−7
21
23
57
82
Profit before tax
515
1 118
834
973
1 059
Tax
113
246
183
214
235
Net profit
401
872
650
759
824
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 541
2 693
2 939
2 762
4 994
Equity
916
1 308
1 236
1 195
1 219
Long-term debt
0
0
0
0
0
Short-term debt
625
1 385
1 703
1 567
3 775
Total debt
625
1 385
1 703
1 567
3 775
Financial ratios
5-year trend
EBITDA margin
14.3%
This company
15.8%
Market median
-9% vs market
2020
2024
Equity ratio
24.4%
This company
38.2%
Market median
-36% vs market
2020
2024
Return on equity
67.6%
This company
18.4%
Market median
+267% vs market
2020
2024
Net profit margin
12.1%
This company
8.1%
Market median
+49% vs market
2020
2024
Asset turnover
1.36×
This company
1.12×
Market median
+21% vs market
2020
2024
Debt / equity
3.10×
This company
0.62×
Market median
-400% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
KA
Karin Andersen
Board of Directors
2021
EA
Espen Andersen
Chairman
2021
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Ka Medical As
Company
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Ka Medical As
ENTOMED NORGE AS
(this company)
Board network connections
Board members of ENTOMED NORGE AS also hold positions in
0
other companies.
Person
Role here
Other companies
Karin Andersen
Board of Directors
0 companies
Espen Andersen
Chairman
0 companies